BioNTech shares slip on gloomy Covid vaccine sales outlook
March 27, 2023 at 12:00 PM EDT
The shares initially fell by 6.4% to an intraday low of $119.98 a share before recovering most of those losses in late morning trading.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following